Viscosupplementation Market Size to Reach USD 11.37 Billion by 2032 Owing to Rising Geriatric Population and Growing Osteoarthritis Incidence

Business Upturn

8 hours ago

Austin, June 29, 2025 (GLOBE NEWSWIRE) — Viscosupplementation Market Size & Growth Analysis:
'According to SNS Insider, the global Viscosupplementation Market was valued at USD 5.48 billion in 2024 and is expected to reach USD 11.37 billion by 2032, expanding at a CAGR of 9.56% over the forecast period of 2025–2032.'
Growing need for minimally invasive osteoarthritis treatment, favourable reimbursement policies, and increasing incidence of knee disorders would contribute to the adoption of viscosupplementation worldwide.
Get a Sample Report of Viscosupplementation Market@ https://www.snsinsider.com/sample-request/7374
U.S. viscosupplementation market was valued at USD 1.21 billion in the year 2024 and is estimated to reach USD 2.50 billion by the year 2032. This expansion is a result of growing FDA approvals, strong presence of key manufacturers, and high adoption of three-injection therapy for osteoarthritis patients in both orthopedic clinics and ambulatory surgical centers.
Market Overview
The viscosupplementation market is growing leaps and bounds as a result of the increasing population with osteoarthritis, especially in the older age segment across the world. As awareness of alternative pain treatments, e.g., minimally invasive, continues to increase, so does the request for hyaluronic acid (HA) injections that are able to restore the viscosity of the damaged synovial fluid in the joints. The treatment has been widely adopted because it is associated with short recovery time, fewer side effects, and more patient satisfaction. In addition, the feasibility of having single- or multiple-injection regimens available facilitates individual treatment planning according to patient preference and extent of disease.
North America dominates the market on account of well-established healthcare infrastructure, increasing adoption across the region, and continued development. At the same time, Asia Pacific is set to be the fastest-growing region on account of the rising accessibility to healthcare, the growing number of orthopedic procedures, and increasing awareness of viscosupplementation. Efforts by the governments of countries like Japan, China, and India to enhance geriatric care are also driving growth in the region.
Major Players Analysis Listed in this Report are: DePuy Synthes
Fidia Farmaceutici S.p.A
Sanofi
Smith & Nephew PLC
Anika Therapeutics, Inc.
Seikagaku Corp.
Zimmer Biomet
Ferring Pharmaceuticals B.V.
Lifecore Biomedical
LG Life Sciences Ltd.
F.Hoffmann-La Roche Ltd.
Viscosupplementation Market Report Scope Report Attributes Details Market Size in 2023 US$ 5.48 billion Market Size by 2032 US$ 11.37 billion CAGR (2024–2032) 9.56% U.S. Market 2023 USD 1.21 billion U.S. Forecast by 2032 USD 2.50 billion Base Year 2023 Forecast Period 2024–2032 Key Regional Coverage North America (US, Canada, Mexico), Europe (Germany, France, UK, Italy, Spain, Poland, Turkey, Rest of Europe), Asia Pacific (China, India, Japan, South Korea, Singapore, Australia, Rest of Asia Pacific), Middle East & Africa (UAE, Saudi Arabia, Qatar, South Africa, Rest of Middle East & Africa), Latin America (Brazil, Argentina, Rest of Latin America)
Segment Analysis
By Product:
The three-injection viscosupplementation segment held the largest market share in 2023, accounting for 42%. This dominance is attributed to its proven long-term efficacy in moderate-to-severe osteoarthritis cases, offering sustained pain relief and improved mobility. Physicians widely prefer this format due to its extensive clinical validation and familiarity.
Meanwhile, the single-injection segment is the fastest-growing product type. Its rapid adoption is driven by increased patient compliance, reduced clinic visits, and lower procedural costs. These benefits are especially appealing in outpatient and resource-constrained settings.
By End-Use:
In 2023, orthopedic clinics and ambulatory surgical centers (ASCs) led the market, contributing 63% of the overall revenue. The rise of outpatient care models, availability of advanced orthopedic expertise, and focus on cost-effective joint pain management have supported this segment's dominance.
Conversely, hospitals are the fastest-growing end-use segment due to the rise in inpatient osteoarthritis treatment, complex case management, and integration of viscosupplementation into broader rehabilitation programs, particularly for elderly and comorbid patients.
For A Detailed Briefing Session with Our Team of Analysts, Connect with Us Now@ https://www.snsinsider.com/request-analyst/7374
Viscosupplementation Market Segmentation
By Product Three Injection
Single Injection
Five Injection
By End-use Hospitals
Orthopedic Clinics/ASCs
Regional Analysis
North America held the largest share of the viscosupplementation market in 2024, driven by a high osteoarthritis patient base, favorable insurance coverage, and strong regulatory backing for HA-based injectables. The U.S. continues to dominate due to established clinical protocols and patient preference for minimally invasive alternatives.
Asia Pacific is the fastest-growing regional market, propelled by increasing healthcare expenditure, improving patient awareness, and rapid urbanization. Growing demand in China, Japan, and India is further stimulated by efforts to reduce surgical interventions through conservative treatment options.
Recent Developments In January 2024, Zimmer Biomet launched a new three-injection viscosupplementation product in select global markets targeting moderate-stage osteoarthritis.
In February 2024, Sanofi announced the rollout of its improved formulation of hyaluronic acid injections across Europe, aimed at extending joint relief duration.
In March 2024, the U.S. FDA approved multiple new single- and three-injection HA-based viscosupplementation products, enhancing treatment availability.
In April 2024, Seikagaku Corporation reported over 2 million units of viscosupplementation products distributed globally during the first half of 2024.
Table of Contents – Major Key Points
1. Introduction
2. Executive Summary
3. Research Methodology
4. Market Dynamics Impact Analysis
5. Statistical Insights and Trends Reporting
6. Competitive Landscape
7. Viscosupplementation Market by Product
8. Viscosupplementation Market by End-use
9. Regional Analysis
10. Company Profiles
11. Use Cases and Best Practices
12. Conclusion
Buy a Single-User PDF of Viscosupplementation Market Analysis & Outlook Report 2024-2032@ https://www.snsinsider.com/checkout/7374
About Us:
SNS Insider is one of the leading market research and consulting agencies that dominates the market research industry globally. Our company's aim is to give clients the knowledge they require in order to function in changing circumstances. In order to give you current, accurate market data, consumer insights, and opinions so that you can make decisions with confidence, we employ a variety of techniques, including surveys, video talks, and focus groups around the world.
Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. Business Upturn takes no editorial responsibility for the same.
Ahmedabad Plane Crash